Cite
Chronic immune thrombocytopentic purpura in children: Assessment of Rituximab treatment
MLA
Harald Reinhard, et al. “Chronic Immune Thrombocytopentic Purpura in Children: Assessment of Rituximab Treatment.” The Journal of Pediatrics, vol. 148, Mar. 2006, p. 423. EBSCOhost, https://doi.org/10.1016/j.jpeds.2005.10.025.
APA
Harald Reinhard, Arend von Stackelberg, Ursula Schulte-Overberg, Tillmann Taube, Hansjörg Schmid, & Günter Henze. (2006). Chronic immune thrombocytopentic purpura in children: Assessment of Rituximab treatment. The Journal of Pediatrics, 148, 423. https://doi.org/10.1016/j.jpeds.2005.10.025
Chicago
Harald Reinhard, Arend von Stackelberg, Ursula Schulte-Overberg, Tillmann Taube, Hansjörg Schmid, and Günter Henze. 2006. “Chronic Immune Thrombocytopentic Purpura in Children: Assessment of Rituximab Treatment.” The Journal of Pediatrics 148 (March): 423. doi:10.1016/j.jpeds.2005.10.025.